Additionally, we have demonstrated that CD44-induced upregulation of HAS1 promotes cell migration, invasion, and MMP9 expression, thereby contributing to ccRCC tumorigenesis and progression. Here, MMP9 is linked to nonpapillary renal cell carcinoma.